Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8888745 | ORGANON | Applicator for inserting an implant |
Aug, 2026
(3 years from now) | |
US10821277 | ORGANON | Kit for and method of assembling an applicator for inserting an implant |
May, 2027
(3 years from now) | |
US8722037 | ORGANON | X-ray visible drug delivery device |
Sep, 2027
(4 years from now) | |
US9757552 | ORGANON | Applicator for inserting an implant |
Jul, 2030
(7 years from now) |
Market Authorisation Date: 17 July, 2006
Treatment: Prevention of pregnancy
Dosage: IMPLANT;IMPLANTATION
13
European Union
7
United States
4
Canada
4
Korea, Republic of
4
Brazil
4
China
4
Japan
4
Argentina
4
New Zealand
4
Australia
4
Norway
4
South Africa
3
Peru
3
Ukraine
3
Hong Kong
3
Taiwan
3
Spain
3
Mexico
3
Portugal
3
Russia
2
Poland
2
Slovenia
2
Denmark
1
Latvia
1
Egypt
1
Lithuania
1
Germany
1
Croatia
1
Malaysia
1
Hungary
1
Austria
1
Ecuador
1
Israel
1
Cyprus
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic